Nelson Advisors referenced by Femovate, leading FemTech and Women's Health innovation accelerator
NA
Femovate Wins #17 - UVISA Health spotlighted in the 20 Future Danish HealthTech and MedTech Leaders report by Nelson Advisors.
"Uvisa Health is a pre-revenue medtech company developing a reusable, insertable phototherapy device to treat persistent vaginal infections. This falls under the rapidly growing "FemTech" category, which is gaining traction in 2026 as investors target underserved demographics with high earning power. Uvisa’s drug-free approach addresses the limitations of standard chemical treatments.
FemTech unicorns like Flo Health are expanding into the menopause and chronic infection markets, creating a fertile environment for M&A and fundraising. Uvisa’s status as an early-stage innovator with a novel delivery mechanism makes it a key company to watch in the women’s health segment of Medicon Valley."
Wonderful to see this women's health startups next to leaders like Dawn Health: https://lnkd.in/dMJvQvPU
About the 50 Femovate Wins:
We're sharing 50 wins from all of the amazing startups in Femovate. The wins might be investments, awards, milestone moments, and reviews from real women saying how much these products and services have impacted their lives. Because that's why Femovate exists, to improve the health of women around the world.
About Femovate
Femovate was created in 2022 to accelerate the investment in, and launch of, women's health innovation. Our team works closely with early stage femtech founders on product vision, go-to-market strategy, female-centered design innovation, MVP support, FDA submissions, clinical studies and the product development lifecycle.
We launched Femovate in 2022 to accelerate the investment in, and launch of, women's health innovation. Since then we've invested $2M in design capital in 60 early-stage femtech startups. The startups, in turn, have launched 30 products, raised over $130 million from investment and grants, four have raised a Series A, and 7 have received FDA clearances.